145 related articles for article (PubMed ID: 8858379)
21. beta Cell autoimmunity in a child with M.O.D.Y. (Maturity Onset Diabetes in the Young).
Ortega-Rodriguez E; Levy-Marchal C; Guillermine S; Polak M
Diabetes Metab; 2001 Feb; 27(1):59-61. PubMed ID: 11240447
[TBL] [Abstract][Full Text] [Related]
22. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.
Krischer JP; Cuthbertson DD; Yu L; Orban T; Maclaren N; Jackson R; Winter WE; Schatz DA; Palmer JP; Eisenbarth GS
J Clin Endocrinol Metab; 2003 Jan; 88(1):103-8. PubMed ID: 12519837
[TBL] [Abstract][Full Text] [Related]
23. Prediction and prevention of Type 1 diabetes mellitus.
Zhang L; Eisenbarth GS
J Diabetes; 2011 Mar; 3(1):48-57. PubMed ID: 21073664
[TBL] [Abstract][Full Text] [Related]
24. Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes.
Verge CF; Gianani R; Yu L; Pietropaolo M; Smith T; Jackson RA; Soeldner JS; Eisenbarth GS
Diabetes; 1995 Oct; 44(10):1176-9. PubMed ID: 7556954
[TBL] [Abstract][Full Text] [Related]
25. T cell autoimmunity to glutamic acid decarboxylase in human insulin-dependent diabetes mellitus.
Lohmann T; Scherbaum WA
Horm Metab Res; 1996 Jul; 28(7):357-60. PubMed ID: 8858386
[No Abstract] [Full Text] [Related]
26. Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure.
Soeldner JS; Tuttleman M; Srikanta S; Ganda OP; Eisenbarth GS
N Engl J Med; 1985 Oct; 313(14):893-4. PubMed ID: 3897867
[No Abstract] [Full Text] [Related]
27. Type 1 diabetes islet autoantibody markers.
Winter WE; Harris N; Schatz D
Diabetes Technol Ther; 2002; 4(6):817-39. PubMed ID: 12614488
[TBL] [Abstract][Full Text] [Related]
28. Antiislet autoantibodies usually develop sequentially rather than simultaneously.
Yu L; Rewers M; Gianani R; Kawasaki E; Zhang Y; Verge C; Chase P; Klingensmith G; Erlich H; Norris J; Eisenbarth GS
J Clin Endocrinol Metab; 1996 Dec; 81(12):4264-7. PubMed ID: 8954025
[TBL] [Abstract][Full Text] [Related]
29. Concordance for islet autoimmunity among monozygotic twins.
Redondo MJ; Jeffrey J; Fain PR; Eisenbarth GS; Orban T
N Engl J Med; 2008 Dec; 359(26):2849-50. PubMed ID: 19109586
[No Abstract] [Full Text] [Related]
30. The prevalence of the 65-kilodalton isoform of glutamic acid decarboxylase autoantibodies by glucose tolerance status in elderly patients from the cardiovascular health study.
Barinas-Mitchell E; Kuller LH; Pietropaolo S; Zhang YJ; Henderson T; Pietropaolo M
J Clin Endocrinol Metab; 2006 Aug; 91(8):2871-7. PubMed ID: 16720660
[TBL] [Abstract][Full Text] [Related]
31. Elimination of dietary gluten does not reduce titers of type 1 diabetes-associated autoantibodies in high-risk subjects.
Hummel M; Bonifacio E; Naserke HE; Ziegler AG
Diabetes Care; 2002 Jul; 25(7):1111-6. PubMed ID: 12087006
[TBL] [Abstract][Full Text] [Related]
32. Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay.
Yu L
Methods Mol Biol; 2016; 1433():85-91. PubMed ID: 26659802
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type I diabetes.
Yu L; Gianani R; Eisenbarth GS
Diabetes; 1994 Oct; 43(10):1229-33. PubMed ID: 7926293
[TBL] [Abstract][Full Text] [Related]
34. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes.
Harrison LC; Honeyman MC; DeAizpurua HJ; Schmidli RS; Colman PG; Tait BD; Cram DS
Lancet; 1993 May; 341(8857):1365-9. PubMed ID: 8098789
[TBL] [Abstract][Full Text] [Related]
35. Autoimmunity to islet cells in diabetes mellitus.
Powers AC; Eisenbarth GS
Annu Rev Med; 1985; 36():533-44. PubMed ID: 3888064
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.
Orban T; Sosenko JM; Cuthbertson D; Krischer JP; Skyler JS; Jackson R; Yu L; Palmer JP; Schatz D; Eisenbarth G;
Diabetes Care; 2009 Dec; 32(12):2269-74. PubMed ID: 19741189
[TBL] [Abstract][Full Text] [Related]
37. Pyridoxal 5'-phosphate (PLP) deficiency might contribute to the onset of type I diabetes.
Rubí B
Med Hypotheses; 2012 Jan; 78(1):179-82. PubMed ID: 22088923
[TBL] [Abstract][Full Text] [Related]
38. Type 1 diabetes: chronic progressive autoimmune disease.
Zhang L; Gianani R; Nakayama M; Liu E; Kobayashi M; Baschal E; Yu L; Babu S; Dawson A; Johnson K; Jahromi M; Aly T; Fain P; Barker J; Rewers M; Eisenbarth GS
Novartis Found Symp; 2008; 292():85-94; discussion 94-8, 122-9, 202-3. PubMed ID: 19203094
[TBL] [Abstract][Full Text] [Related]
39. Birth and coming of age of islet autoantibodies.
Bonifacio E; Achenbach P
Clin Exp Immunol; 2019 Dec; 198(3):294-305. PubMed ID: 31397889
[TBL] [Abstract][Full Text] [Related]
40. Transient antiislet autoantibodies: infrequent occurrence and lack of association with "genetic" risk factors.
Yu J; Yu L; Bugawan TL; Erlich HA; Barriga K; Hoffman M; Rewers M; Eisenbarth GS
J Clin Endocrinol Metab; 2000 Jul; 85(7):2421-8. PubMed ID: 10902788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
